Federation Des Caisses Desjardins Du Quebec Applied Therapeutics Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 84 shares of APLT stock, worth $18. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84
Previous 84
-0.0%
Holding current value
$18
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
77Shares Held
97.7MCall Options Held
357KPut Options Held
301K-
T. Rowe Price Investment Management, Inc. Baltimore, MD21.4MShares$4.71 Million0.01% of portfolio
-
Vestal Point Capital, LP New York, NY14.3MShares$3.14 Million0.39% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$2.48 Million6.83% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$1.72 Million2.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$1.45 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $10.6M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...